XML 42 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation Expense (Tables)
 3 Months Ended
Mar. 31, 2024
Stock-Based Compensation Expense [Abstract]  
Schedule of Stock Options Vested and Exercisable The following table summarizes information about the Company’s stock options outstanding as well as stock options vested and exercisable as of March 31, 2024, and activity during the three month period then ended:
   Shares   Weighted-average exercise
price		   Weighted-average remaining
contractual
term
(years)		   Aggregate
intrinsic
value		 
Outstanding as of December 31, 2023   17,503,253   $1.04    7.37   $42,527 
Granted   245,500    0.20           
Exercised   
-
    
-
         - 
Cancelled/forfeited   (631,354)  $1.32           
Outstanding as of March 31, 2024   17,117,399   $1.02    7.11   $104,727 
Vested and expected to vest at March 31, 2024   17,117,399   $1.02    7.11   $104,727 
Vested and exercisable at March 31, 2024   9,205,674   $0.96    5.68   $104,727 
Schedule of Restricted Stock Units and Activity The following table summarizes information about the Company’s RSUs as of March 31, 2024, and activity during the three months then ended:
   Shares   Weighted-
average
grant date
fair value		 
Unvested Shares at December 31, 2023   177,294   $2.80 
RSUs granted   
-
    
-
 
RSUs vested   (12,228)   5.52 
RSUs forfeited   
-
    
-
 
Unvested Shares at March 31, 2024   165,066   $2.60 
Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values The following weighted average assumptions were used in estimating the grant date fair values for the three months ended March 31, 2024 and 2023:
   March 31, 
   2024   2023 
Fair value of common stock  $0.20   $1.06 
Expected term (in years)   6.01    6.03 
Risk-free rate   4.10%   3.73%
Expected volatility   53.06%   52.50%
Dividend yield   0%   0%